Media Release: CSL to Move Global Headquarters to Parkville Biomedical Precinct

08 Aug 2019

CSL announced yesterday that they are moving their global headquarters to the Melbourne Biomedical Precinct.
CSL Limited will build world-class laboratories and offices in a 16-storey flagship building located at 645 Elizabeth Street on the northern edge of Melbourne’s CBD.
The flagship building at ‘Elizabeth North’ will house more than 800 CSL employees including product development teams, commercial operations, corporate functions and support services.
We are very pleased that CSL will maintain its global research hub at the Bio21 Institute which currently accommodates 130 CSL researchers in the Nancy Millis and Penington buildings.
The University of Melbourne: University of Melbourne Vice-Chancellor Professor Duncan Maskell said, "The relationship between CSL and University of Melbourne goes back over 50 years and is an outstanding example of industry and university collaboration. CSL already has a strong presence in the Melbourne Biomedical Precinct through its partnership with the University’s Bio21 Institute of Molecular Science and Biotechnology. CSL’s announcement is a testament to our strong partnership and we look forward to collaborating on important research projects to generate real impacts in medicine."
These new developments taking place within our precinct will strengthen our biomedical sector, will provide opportunities for our researchers and strengthen our ties within our own Bio21 community.
Please use this link for more information from the official CSL announcement.